Authors:
LAMARRE D
CROTEAU G
WARDROP E
BOURGON L
THIBEAULT D
CLOUETTE C
VAILLANCOURT M
COHEN E
PARGELLIS C
YOAKIM C
ANDERSON P
Citation: D. Lamarre et al., ANTIVIRAL PROPERTIES OF PALINAVIR, A POTENT INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 965-971
Authors:
CROTEAU G
DOYON L
THIBEAULT D
MCKERCHER G
PILOTE L
LAMARRE D
Citation: G. Croteau et al., IMPAIRED FITNESS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITHHIGH-LEVEL RESISTANCE TO PROTEASE INHIBITORS, Journal of virology, 71(2), 1997, pp. 1089-1096
Authors:
BEAULIEU PL
WERNIC D
ABRAHAM A
ANDERSON PC
BOGRI T
BOUSQUET Y
CROTEAU G
GUSE I
LAMARRE D
LIARD F
PARIS W
THIBEAULT D
PAV S
TONG L
Citation: Pl. Beaulieu et al., POTENT HIV PROTEASE INHIBITORS CONTAINING A NOVEL (HYDROXYETHYL)AMIDEISOSTERE, Journal of medicinal chemistry, 40(14), 1997, pp. 2164-2176
Authors:
DOYON L
CROTEAU G
THIBEAULT D
POULIN F
PILOTE L
LAMARRE D
Citation: L. Doyon et al., 2ND LOCUS INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE TO PROTEASE INHIBITORS, Journal of virology, 70(6), 1996, pp. 3763-3769
Authors:
FLEURY S
HUANG B
ZERBIB A
CROTEAU G
LONG EO
SEKALY RP
Citation: S. Fleury et al., MUTATIONS IN HUMAN CD4 IMPAIR THE FUNCTIONAL INTERACTION WITH DIFFERENT HUMAN AND MOUSE CLASS-II ISOTYPES AND ALLELES, The Journal of immunology, 156(5), 1996, pp. 1848-1855
Authors:
LAMARRE D
DOYON L
CROTEAU G
PILOTE L
THIBEAULT D
Citation: D. Lamarre et al., MOLECULAR-BASIS OF HIV-1 RESISTANCE TO PROTEASE INHIBITORS - STRUCTURAL FLEXIBILITY OF THE PROTEASE AND 2ND-SITE COMPENSATORY MUTATIONS IN CLEAVAGE SITES, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 62-62
Citation: G. Croteau et J. Alpert, PROBLEM PREVENTION STRATEGIES - LOW-TECH APPROACHES TO COMPOSTING SUPERMARKET ORGANICS, Biocycle, 35(5), 1994, pp. 74